Hematopoiesis: An ASH Trainee Council Production American Society of Hematology

Tune in to the Hematopoiesis podcast to hear a conversation about the increasingly relevant topic of geriatric hematology. Many blood disorders and hematologic malignancies are diseases of older adults, and in this introduction to geriatric hematology, Drs. Maya Abdallah and Ajay Major talk about “staging the aging.”
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/.

Join Physician Scientist and Nobel Laureate Dr. Bill Kaelin and Dr. Eric Vick of the ASH Trainee Council to discuss choosing your target as a physician scientist, discussing your choice of target in your career and in your scientific exploration.
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/.

In this episode, Trainee Council Chairs, Drs. Becky Zon and Ajay Major, interview Dr. Nancy Berliner, Blood Editor-in Chief and Dr. Andrew Roberts, Blood Deputy Editor, on their careers in academic editing and publishing, including career development tips for trainees who are interested in a career in publishing.
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/.

In the second episode of this Hematopoiesis Bench to Bedside series, Dr. Manuel Espinoza-Gutarra has conversations with Dr. Aaron Mitchell, Dr. Yousuf Zafar (@yzafar), Dr. Aju Mathew, and Dr. Nandita Khera (@khera_nandita), experts in the field of financial toxicity in cancer patients, who offer different perspectives regarding the impact of the financial costs of modern anticancer treatment puts on patients, how should we adequately measure it and how to tackle it.
Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/.

In this episode of Hematopoiesis, Dr. Alexis Caulier has exciting conversations with three experts in the field about how early bench work on the genetic regulation of fetal hemoglobin led to the development of bedside gene therapies. Dr. David Nathan revisits the beneficial role of fetal hemoglobin to improve the clinical manifestations of hemoglobinopathies. Dr. Vijay Sankaran (@bloodgenes) highlights the great impact of studying gene regulatory networks in developing innovative gene therapies, and Dr. Courtney Fitzhugh (@CourtneyFitzhu1) emphasizes the importance and the specificities of clinical trials for innovative therapies.

In the third episode of this Hematopoiesis Women in Hematology three-part series, Dr. Becky Zon (@beckyzon) has a conversation with Director of the Haematology Clinical Trials Unit at St. Vincent’s Hospital in Australia Dr. Nada Hamad (@nadahamad). Dr. Hamad shares her experiences as a lymphoma/bone marrow transplant/cellular therapies clinician, President of the ANZTCT, an intersectional feminist, and Vogue magazine star.  Music: “Somebody New” RYYZN (www.toneden.io/ryyzn/post/somebody-new-copyright-free). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/.